Beloxamide

This classification denotes an anti-lipidemic agent with the molecular formula C18H21NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S4YR4X39CA, chemically known as acetamide, n-(phenylmethoxy)-n-(3-phenylpropyl)- but generally known as beloxamide, which bears US NIH Compound Identifier 27155. European Medicines Agency schedules Beloxamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05688MIG. The term BELOXAMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 24, No. 11 1970, List 10). BELOXAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule beloxamide under HS 29280090 and SITC 51486. As of Q4 2014, BELOXAMIDE remains the US FDA Preferred Term for this commodity. Beloxamide bears US NLM identifiers UMLS ID C0053081 and NCI Concept Code C78050. SMILES: O(N(CCCc1ccccc1)C(=O)C)Cc1ccccc1.